Aurora Cannabis Inc. (ACB)
Pre-market:
| Previous close | 7.61 |
| Open | 7.61 |
| Bid | 7.35 x 1100 |
| Ask | 7.42 x 800 |
| Day's range | 7.18 - 7.64 |
| 52-week range | 2.84 - 11.50 |
| Volume | |
| Avg. volume | 7,955,327 |
| Market cap | 402.562M |
| Beta (5Y monthly) | 2.65 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -58.24 |
| Earnings date | 12 Jun 2024 - 17 Jun 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 31.96 |
ZacksStrength Seen in Canopy Growth (CGC): Can Its 11.0% Jump Turn into More Strength?
Canopy Growth (CGC) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
PR NewswireAurora Cannabis Announces Appointment of New Director
Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian based leading global medical cannabis company, announced today the appointment of Rajesh Uttamchandani to the Company's Board of Directors (the "Board"), effective today.
PR NewswireAurora Marks First Shipment of Medical Cannabis to the New Zealand Market
Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) the Canadian based leading global medical cannabis company, is proud to announce the arrival of Aurora branded medical cannabis products to the New Zealand market. This new line of premium dried flowers represents a significant milestone in medical cannabis accessibility in New Zealand, an emerging market poised for growth.
